Global Coalition on Aging Experts Headline First World Congress on Healthy Ageing

Coalition Brings Business Perspective to Global Aging Dialogue

KUALA LUMPUR, MALAYSIA (Mar. 19, 2012) – The Global Coalition on Aging will lead two plenary sessions during the First World Congress on Healthy Ageing, calling for business, government, NGOs, communities, and individuals to take action toward increasing personal well being, productivity and economic growth as societies are aging at unprecedented rates. The Global Coalition is a main supporter of the congress, which takes place March 19-22 in Kuala Lumpur, Malaysia.

“The creation of good health policy today in light of 21st-century aging trends is essential economic policy for tomorrow, as nations must prepare for the imminent onslaught of non-communicable diseases (NCDs), like diabetes, cancers, cardiovascular disease and Alzheimer’s, which are rapidly increasing in terms of prevalence and costs as we age,” said Coalition Executive Director Michael Hodin. “This congress is especially timely as the EU celebrates its Year of Healthy and Active Aging and the World Health Organization focuses World Health Day 2012 on aging and health. The Global Coalition on Aging applauds the Malaysian Healthy Ageing Society and the WHO for organizing this groundbreaking event, which will lead the way toward identifying the policies and partnerships that will bring about real change across the Asia-Pacific and the globe.”

Population aging – a combination of longer life and a decrease in birth rates – is leading to a shift in the size and proportion of those traditionally viewed as “old” compared to “young.” To address this shift, the Global Coalition envisions nothing short of defining a new middle age – 55 to 75 – around which policy and markets will enable an active and healthier life that transforms this demographic cohort from being dependent to becoming economic contributors.

The congress will welcome more than 1,000 leaders and innovators from across health care, government, business, and academia. The two sessions presented by the Global Coalition are:

  1. March 20: “Investment in Health as Economic Policy for 21st-Century Active Aging” will focus on how economic policy and health policy are inextricably linked, bringing particular focus on non-communicable diseases (NCDs) as cost drivers that demand a call for action, and
  2. March 22: “New Approaches to Healthy Ageing from Across the Globe” will present examples from the region and from global business to highlight how innovation and collaborative efforts are critical in changing the mindset and taking action to turn population aging into opportunity.

“We welcome the Global Coalition’s business perspective to the congress and the Asia-Pacific region, in which we have both developed and developing nations seeing incredible growth in the 60-plus population over the next few decades,” said Assoc. Prof. Nathan Vytialingam, President of the Malaysian Healthy Ageing Society and Organising Chairman of the 2012 Congress.  According to the United Nations Economic and Social Commission for Asia and the Pacific, 62 percent of the world’s 60-plus population, or 1.2 billion people, will live in Asia in 2050. “In our region and globally, we pledge to work with the Coalition and other like-minded partners within business, government, NGOs, and other innovators to find solutions that promote healthy aging and opportunities for growth.”

Experts headlining the Coalition plenary sessions include:

  • John Beard, Director of the Department of Ageing and Life Course, World Health Organization (Switzerland)
  • Dan Brindle, Senior Director, International Public Affairs & Policy (Asia), Pfizer (China)
  • Antonio Dans, President, Philippine Society of General Internal Medicine; Professor, University of the Philippines College of Medicine, Department of Medicine, UP College of Medicine (Philippines)
  • William Green, Director of Public Affairs and Relations, Nutricia Advanced Medical Nutrition (The Netherlands)
  • Prof. Anindya Mishra, Assistant Professor, Department of Humanities and Social Sciences, Indian Institute Technology, Roorkee (India)
  • Melissa Mitchell, Deputy Director, Global Coalition on Aging (United States)
  • Gregor Rae, Chairman and CEO, BusinessLab and ActiveAge (United Kingdom)

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

GCOA Sign-on Letter to Governor Spanberger: Consequences of Importing Federal Price Caps on Virginians’ Access to Medicine & Healthy Aging Opportunities

Dear Governor Spanberger: We, the undersigned organizations, bring deep, on‑the‑ground experience serving older Americans, patients managing complex and chronic conditions, and their caregivers across Virginia and nationwide. We also have a clear understanding of which policies and programs are effective and where they fall short.

New Report Summarizes State of Expert Opinions on Japan’s Adult Vaccine Policy as Population Shifts Older

The Global Coalition on Aging (GCOA), Health and Global Policy Institute (HGPI), and the Asia-Pacific Consortium for Healthy Aging and Adult Immunization (AP-CHAAI) today announced the launch of Strengthening Vaccine Policy for Healthy Aging and Economic Growth in Japan, a landscape analysis examining the state of vaccine policy in super-aging Japan. Based on a comprehensive review of over 100 policy documents, recommendations, reports, academic papers, and gray literature articles, the report, which was funded by GSK, summarizes the latest academic research and policy discourse around adult vaccines.

WSJ Letter to the Editor: How Flu Vaccine Policies Affect the Economy

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will have negative consequences. Mr. Prasad’s decision to reject Moderna’s flu vaccine without even reviewing it is even worse than you describe. Denying us a new, innovative flu vaccine is horrible health policy. Innovation is at risk because, as Moderna’s CEO has said, if the largest market is off limits, investments won’t be made. But the decision will also have economic consequences. Investment in preventive health is critical as our population ages. In its April 2025 World Economic Outlook report, the International Monetary Fund dedicated an entire chapter to the need for healthier longevity as the global population ages.

Joe Biden’s ‘Cancer Moonshot’ May be Derailed by New Policies, Including His Own

For almost a decade, President Biden has championed a bold “cancer moonshot” — an initiative he first launched in 2016, revived early in his administration, and reiterated during this year’s State of the Union. It is a laudable goal, especially for an aging nation where cancer and chronic disease are on the rise. There’s just one problem: Recent federal and state policies are poised to derail the incredible progress made in oncology since 2016. A rash of policies now threatens to limit access and slow progress towards new breakthroughs.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

Kishida and Biden Face a Similar Demographic Crisis

Your front page story “Japan wrestles with age-old problem as population declines at record rate” (Report, April 13) and the letter in the same edition from Tim Hill, “A gently declining population is no reason to panic”, both describe what all societies face as they modernise in the 21st century.

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.